baber/WOPTO huggingface dataset:
Patent JP-3308840-B2 (JP)
IPC: F02D41/22
Filed: 1996-12-24
Granted: 2002-07-29
Abstract: PROBLEM TO BE SOLVED: To reduce a cost and to save a space for a wiring without changing a rule of fail safe by a method wherein a signal transmitted through a communication line is compared with a source switch recognition signal and according to the comparing result, closing and breaking of a power source to a device are controlled. SOLUTION: A switch signal is inputted to an ECU 1 through one signal input wire W to effect processing of a signal. A system source control part 2 first decides it from an input signal (b) forming an L level whether press of a switch SW1 is effected and secondly decides it from a signal (a) forming an L level whether the main switch SW1 is pressed. A power source is controlled on that particular time when both the signals (a) and (b) are an L level. Further, when abnormality occurs in a signal processing part 4, the signal a always produces an H level. When the signal wire W is disconnected, a signal equivalent to a cancel switch S4 is inputted to the ECU 1, thereby ensuring safety of a device.
Patent JP-3258665-B2 (JP)
IPC: B01J8/26
Filed: 1994-05-16
Granted: 2002-02-18
Abstract: Particles in a fluidized bed reactor (e.g. a circulating fluidized bed reactor) are discharged from the reactor chamber and then cooled (heat is recovered from them) in a processing chamber. This is accomplished in a particularly advantageous way by discharging the particles from the reactor chamber at a first level (e.g. through a non-mechanical seal or a classifying wall) into a lifting chamber. Upwardly flowing gas in the lifting chamber entrains the particles and lifts them into the processing chamber. After processing, the particles in the processing chamber are returned to the reactor chamber at level higher than the first level, at which point the pressure in the processing chamber is higher than the pressure in the reactor chamber. The particles may be classified in the lifting chamber by utilizing fluidizing gas to transport solid particles smaller than a predetermined size to the processing chamber while discharging larger particles from the bottom of the lifting chamber.
Patent JP-2557586-B2 (JP)
IPC: C07C45/82
Filed: 1990-12-28
Granted: 1996-11-27
Abstract: PCT No. PCT/FR90/00958 Sec. 371 Date Oct. 31, 1991 Sec. 102(e) Date Oct. 31, 1991 PCT Filed Dec. 28, 1990 PCT Pub. No. WO91/09830 PCT Pub. Date Jul. 11, 1991.An improved method for preparing citral in liquid phase from prenol and prenal, wherein, in a single reaction enclosure, the prenol and prenal are condensed in the presence of a mineral acid at a concentration of about 5.10-3 mole for one mole of prenal, 90 to 95% of the acid is neutralized, and once excess prenal and prenol is eliminated, the citral is distilled.
Patent JP-H0685799-B2 (JP)
IPC: A61M1/00
Filed: 1985-08-20
Abstract: A wound drainage system includes a collection chamber (7) for receiving fluids from a patient's body, a suction chamber (3) communicatable with the collection chamber (7) and connectable to a suction source (Ps) and a suction regulator (5) for controlling the pressure in the suction chamber (3). Venturi means (101,101') are provided for admitting gases from the collection chamber (7) into the suction chamber (3) at a flow rate according to the pressure differential between the collection chamber (7) and the suction chamber (3). Gas flow measuring means communicate with the throat (109,109') of the venturi means (101,101'). The gas flow measuring means may be a measuring tube (111) with a bobbing member (115) disposed therein, the bobbing member (115) assuming a position according to the said flow rate, and a scale calibrated to cooperate with the bobbing member (115); or, in an alternative embodiment, may be a measuring chamber (119) which has an air flow diaphragm (121) in one of its walls, whereby the diaphragm (121) flexes in proportion to the said flow rate and moves a dial (125) which cooperates with a scale (131) to indicate the said flow rate. In another embodiment, an opening (15) in a wall dividing the collection chamber is provided with closing means such as a flap valve (11) which opens in proportion to the rate of flow of gas through the opening (15) and operates a dial means (17) co-operating with a scale (21) calibrated to indicate the said rate of flow. <IMAGE>
Patent JP-4119952-B2 (JP)
IPC: C12N15/867
Filed: 1996-06-24
Granted: 2008-07-16
Abstract: The present invention relates to encapsulated cells producing viral particles, especially retroviral particles containing the genome of a retroviral vector carrying therapeutic genes, to methods for the preparation of such encapsulated cells, as well as to the use of such encapsulated cells for the delivery of genes, especially therapeutic genes, to target organs/cells.
Patent JP-H0681596-B2 (JP)
IPC: C12N15/70
Filed: 1988-05-27
Abstract: A recombinant DNA molecule is claimed comprising a nucleotide sequence which codes on expression for a fusion protein in which a foreign protein or peptide is fused with a glutathione-S-trasferase (GST) enzyme. Pref. the enzyme is a 26kD GST of Schistosoma japonicum. The foreign protein or peptide may be fused to the enzyme through a lint cleavable by e.g. thrombin, blood coagulation factor Xa or renin. Also claimed is an expression vector having inserted a nucleotide sequence capable of being expressed as a GST enzyme followed by at least one restriction endonuclease recognition site for insertion of a nucleotide sequence capable of being expressed as a Foreign protein or peptide fused to the GST. The fusion protein is also claimed.
Patent JP-2519029-B2 (JP)
IPC: A61F13/00
Filed: 1985-10-31
Granted: 1996-07-31
Abstract: Systems and their methods of preparation and use that release an active agent in a controlled manner for an extended period in a vaginal cavity environment. When an antifungal agent, such as an imidazole, is incorporated into the system it has been found that the conventional treatment time is reduced by at least 25%.
Patent JP-3038917-B2 (JP)
IPC: H01J49/42
Filed: 1992-08-28
Granted: 2000-05-08
Abstract: A mass spectrometry method in which a supplemental AC voltage signal having at least one high power frequency component, and at least one low power frequency component, is applied to an ion trap. Each high power component has an amplitude sufficiently large to eject one or more selected ions from the trap, by resonantly exciting the ions. Each low power component has an amplitude sufficient to induce dissociation (or reaction) of one or more selected ions, but insufficient to resonate the ions for detection. The frequency (or band of frequencies) of each high and low power frequency component is selected to match a resonance frequency of ions having a desired mass-to-charge ratio. Each low power component is applied for the purpose of inducing dissociation or reaction of specific trapped ions, which may be parent, daughter, reagent, or product ions, and each high power component is applied to eject undesired products of each such dissociation or reaction process from the trap. In accordance with the invention, a supplemental voltage signal having appropriately selected high and low power frequency components is applied to a trap during an (MS)n or CI, or combined CI/(MS)n, mass spectrometry operation.
Patent JP-2568910-B2 (JP)
IPC: G01N33/543
Filed: 1988-04-13
Granted: 1997-01-08
Abstract: A method for obtaining an actual linear standard curve in a sandwich type of immunoassay where a first antibody bound to an insoluble support and a second unbound labelled antibody complex with the antigen contained in a test sample to form an insoluble antibody:antigen:labelled antibody complex which is then detected. Unbound unlabelled first antibody and/or unbound unlabelled second antibody are added to the reaction mixture to divert excess antigen away from the desired end-product complex, thus rendering the antigen of interest the rate-limiting factor in the overall immunoreaction. This results in a pseudo first-order reaction which produces an actual linear standard curve.
Patent JP-H0668017-B2 (JP)
IPC: C08G61/10
Filed: 1986-10-24
Abstract: Phenolic resins are prepared by reacting about 1 to 100 gram/100 ml of a phenol with a peroxidase or an oxidase enzyme and a peroxide in an organic solvent containing medium to generate phenolic radicals which react to form a phenolic resin, which is recovered.
Patent JP-2758184-B2 (JP)
IPC: C07K19/00
Filed: 1988-06-22
Granted: 1998-05-28
Abstract: An immunogenic particle comprises a plurality of first peptide monomers and a plurality of second peptide monomers, each of said first peptide monomers comprising: an amino acid sequence corresponding to a substantial portion of a peptide which upon secretion will form particles which are at least 10nm in diameter, and      an amino acid sequence corresponding to a Hepatitis A epitope, each of said second peptide monomers comprising an amino acid sequence corresponding to a substantial portion of a peptide which upon secretion will form particles which are at least 10 nm in diameter, each of said second peotide monomers being free of an amino acid sequence corresponding to a Hepatitis A epitope, wherein said first peptide monomer and said second peptide monomer are not identical but are capable of binding together.
Patent JP-4047382-B2 (JP)
IPC: B22F9/28
Filed: 1996-08-02
Granted: 2008-02-13
Abstract: A method for chemical vapor deposition using a very fine atomization or vaporization of a reagent containing liquid or liquid-like fluid near its supercritical temperature, where the resulting atomized or vaporized solution is entered into a flame or a plasma torch, and a powder is formed or a coating is deposited onto a substrate. The combustion flame can be stable from 10 torr to multiple atmospheres, and provides the energetic environment in which the reagent contained within the fluid can be reacted to form the desired powder or coating material on a substrate. The plasma torch likewise produces the required energy environment, but, unlike the flame, no oxidizer is needed so materials stable in only very low oxygen partial pressures can be formed. Using either the plasma torch or the combustion plasma, coatings can be deposited and powders formed in the open atmosphere without the necessity of a reaction chamber, but a chamber may be used for various reasons including process separation from the environment and pressure regulation.
Patent JP-3148214-B2 (JP)
IPC: A61P31/12
Filed: 1989-08-02
Granted: 2001-03-19
Abstract: A new virus not neutralized or bound by monoclonal antibodies which bind and neutralize all IBD vaccines of current art, and capable of inducing infectious bursal disease in poultry is identified, in essentially pure form. A test kit, and assay for the presence of the virus is disclosed, together with the vaccine incorporating the virus.
Patent JP-4010344-B2 (JP)
IPC: H02K37/00
Filed: 1998-07-17
Granted: 2007-11-21
Abstract: An electronically commutated claw pole motor has an external rotor (42) with a shaft (40) and a rotor magnet (62). The claw pole motor contains a stator (64) which has a first soft ferromagnetic stator pole piece (74) located on its side facing away from the external rotor (42). The stator pole piece is provided with first claw poles (82, 84) projecting toward the external rotor (42). The stator has a second soft ferromagnetic stator pole piece (76) located on its side facing the external rotor (42). The second soft ferromagnetic pole piece is provided with second claw poles (88, 90) extending from the external rotor (42) and having a larger axial extension (h2) than the first claw poles (82, 84) and projecting into gaps (92) between the first claw poles (82, 84). An axial bearing (44, 46) supports the end (44) of the shaft (40) which faces away from the external rotor (42). In order to generate a magnetic force (F) acting on this bearing, the rotor magnet is displaced, relative to the stator (64), in a direction away from the axial bearing (40, 44).
Patent JP-3017280-B2 (JP)
IPC: B32B7/12
Filed: 1990-07-10
Granted: 2000-03-06
Abstract: PCT No. PCT/DK90/00179 Sec. 371 Date Jan. 7, 1992 Sec. 102(e) Date Jan. 7, 1992 PCT Filed Jul. 10, 1990 PCT Pub. No. WO91/00945 PCT Pub. Date Jan. 24, 1991.A bituminous sheet or web coating material (1) is on the one side provided with a heat activatable adhesive layer (3) optionally covered by a plastic film (5), wherein the adhesive layer is provided with a pattern of close grooves (4) with intermediate unbroken ridges, and a process for forming a coating on a support is performed by heating such coating material (1) to decomposition of said plastic film (5) and activation of the adhesive layer (3), the activated adhesive layer (3) being pressed against the support, e.g. a roof.
Patent JP-3585494-B2 (JP)
IPC: C09D11/08
Filed: 1994-10-13
Granted: 2004-11-04
Abstract: A method of making an emulsion ink is provided. The method includes mixing an ink precursor and processing the ink precursor in a homogenizer to form an emulsion ink. The ink precursor includes a pigment, water, a film forming polymer, an oil and, preferably, a pH dependent thickener and a base.
Patent JP-3210011-B2 (JP)
IPC: H01L41/09
Filed: 1991-07-31
Granted: 2001-09-17
Abstract: A bending transducer (1) has a graphite fibre layer (2) glued by means of an epoxy resin (8) between two piezoceramic layers (10, 12) on both sides of which are arranged electrodes (14, 16). The graphite fibre layer (2) is longer (l) than both piezoceramic layers (10, 12). On the free part of this layer (2) is glued a copper foil (18) upon which is arranged a surface for applying a soldering contact (16). In this way it is relatively easy to bond the electrodes (14i, 16i) that lie inside the transducer.
Patent JP-3210665-B2 (JP)
IPC: C07D498/04
Filed: 1991-07-26
Granted: 2001-09-17
Abstract: A benzopyran derivative represented by general formula (I), which has a K<+> channel activating effect and so is widely applicable for treating, for example, asthma and epilepsy, wherein X represents =O, =S, =N-Z (wherein Z represents lower alkyl, etc.), or = CHNO2; Y represents substituted amino, alkoxy, alkylthio, etc.; and R1 to R7 represent each hydrogen, lower alkyl, etc. <CHEM>
Patent JP-3706130-B2 (JP)
IPC: C07K14/055
Filed: 1993-01-07
Granted: 2005-10-12
Abstract: What is described is a recombinant poxvirus, such as fowlpox virus, containing foreign DNA from Marek's disease virus. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine.
Patent JP-3836500-B2 (JP)
IPC: C12N5/20
Filed: 1993-03-30
Granted: 2006-10-25
Abstract: The invention relates to a monoclonal antibody directed against the human interferon class I receptor (IFN-R) characterized by the following properties: it recognizes the extracellular domain of the human IFN-R, and it has a neutralizing capacity against the biological properties of the human type I-IFN. It further concerns their use for the diagnosis.
Patent JP-3356433-B2 (JP)
IPC: C08J9/00
Filed: 1994-01-21
Granted: 2002-12-16
Abstract: Dense star polymers or dendrimers, modified by capping with a hydrophobic group capable of providing a hydrophobic outer shell, act as molecular nucleating agents. These modified dense star polymers or dendrimers are particularly effective for the production of small cell foams.
Patent JP-2620989-B2 (JP)
IPC: A23L9/20
Filed: 1991-11-12
Granted: 1997-06-18
Abstract: Mesomorphic phases of edible surfactants can advantageously be added to food products to provide for example structuring or fat-replacement. Preferably the mesomorphic phases are present as bulk phases in finished or ready to eat food products.
Patent JP-3666667-B2 (JP)
IPC: C07C233/47
Filed: 1993-04-27
Granted: 2005-06-29
Abstract: Obesity is treated by the administration to a subject of a compound having the general formula (I): R4-(CH2)n-CO-N(R1)-CH(R2)-CO(-R3), wherein R1 represents H or CH3; R2 represents a side chain of a naturally occurring amino acid; R3 represents OH, OCH2CH3 and NH2; n is 6-18; and R4 represents CH3 or a group having the general formula (II): R3-CO-CH(R2)-N(R1)-CO-, wherein R1, R2 and R3 have the above meanings. The compounds of formula (I) wherein R4 is a group of formula (II), are novel compounds.
Patent JP-2866743-B2 (JP)
IPC: A61K31/445
Filed: 1994-11-21
Granted: 1999-03-08
Abstract: PCT No. PCT/IB94/00365 Sec. 371 Date Oct. 24, 1996 Sec. 102(e) Date Oct. 24, 1996 PCT Filed Nov. 21, 1994 PCT Pub. No. WO95/20587 PCT Pub. Date Aug. 3, 19953R*4S*3-[4-(4-fluorophenyl)-4-hydroxy-piperidin-1-yl]-chroman-4,7-diol, its enantiomers and pharmaceutically acceptable salts are effective oral agents for treating diseases and conditions susceptible to treatment by NMDA blocking drugs.
Patent ES-2188365-B2 (ES)
Title: Desarrollo de un proceso integrado de oxidacion avanzada con recuperacion y reutilizacion del catalizador homogeneo de cobre.
Inventor: GUINDULAIN VIDONDO FELIX
IPC: G07F13/06
Filed: 2001-05-04
Granted: 2010-06-02
Abstract: Sistema de aporte directo del azúcar en máquinas
automáticas expendedoras de bebidas calientes. 
     Sistema de aporte directo del azúcar en máquinas
automáticas expendedoras de bebidas calientes, siendo del tipo de
máquinas automáticas expendedoras de bebidas calientes, tales como
café, otras infusiones o chocolate, en cuya selección se proporciona
un vaso (4) para el vertido del producto seleccionado, así como
otros elementos, de forma que en el depósito (5) de almacenaje del
azúcar queda montado con su boca de salida sobre el punto de
recepción de los vasos (4) de vertido del producto seleccionado y en
proximidad a los mismos, presentando, en relación a la boca de
salida del azúcar de aporte directo al correspondiente vaso (4) de
vertido del producto seleccionado, una compuerta (13) accionada por
un motor o una bobina (14).
Patent ES-2323204-B2 (ES)
Title: Espectrometro de imagen y metodo de espectroscopia de imagen.
Inventor: MONTERO ORILLE CARLOS
IPC: G01B9/02
Filed: 2006-10-06
Granted: 2010-02-15
Abstract: Espectrómetro de imagen y método de
espectroscopía de imagen. 
     El espectrómetro de imagen comprende un módulo
de formación de imagen (1)  para proyectar una imagen de un objeto
sobre un módulo de dispersión (2)  configurado para captar una
franja de dicha imagen y descomponerla en una  pluralidad de
componentes espectrales, que son detectadas por un módulo  de
detección (3). Asociado al módulo de formación de imagen (1) hay al 
menos un dispositivo dispersor (D, D41, D51) configurado para formar
un  conjunto de imágenes del objeto desplazadas lateralmente, cada
una de ellas  correspondiente a una banda espectral diferente, de
manera que la franja  captada por el módulo (2) de dispersión
comprende una pluralidad de componentes  espectrales que cada una
corresponde a una franja espacial distinta del  objeto. La invención
también se refiere a un método de espectroscopia de  imagen.
Patent ES-2353769-B2 (ES)
Title: Reproducciones dentales de morfología humana a partir del tallado de huesos animales para su uso en la docencia académica la investigación, la práctica clínica o la industria.
Inventor: VALLE GONZALEZ ANTONIO DEL
IPC: A61C11/00
Filed: 2009-01-13
Granted: 2011-07-29
Abstract: Reproducciones dentales de morfología humana a
partir del tallado de huesos animales para su uso en la docencia
académica, la investigación, la práctica clínica o la industria. 
     La presente invención se refiere al empleo de
huesos largos de origen animal en el que  mediante el tallado de las
corticales óseas se consigue la conformación y fabricación de
dientes de morfología humana para su uso en la docencia académica,
la investigación, la práctica  clínica o la industria. Estas
reproducciones dentales, por estar realizadas en hueso, permiten,
con claras ventajas sobre otro materiales, para practicar cavidades,
obturaciones y otros tratamientos dentales con igual instrumental y
productos que los descritos en cualquier manual de Odontología.
Patent IE-S86410-B2 (IE)
Title: Compositions comprising PEG and ascorbate
Inventor: CLAYTON LUCY
IPC: A61K31/00
Filed: 2013-09-10
Abstract: The invention provides a colon cleansing solution comprising (a) 300 to 800 mmol per litre ascorbate anion provided by a mixture of (i) ascorbic acid and (ii) one or more salts of ascorbic acid - the components (i) and (ii) being present in a molar ratio of from 1:4.5 to 1:7.0; and (b) 10 to 200g per litre polyethylene glycol. The invention also provides methods and kits associated with, or making use of, the solutions and compositions for the preparation of the solutions.
Patent IE-S86985-B2 (IE)
Title: Organic synthesis intermediates 4-nitro-1,8-naphthalic acid synthesis method
Inventor: FEI PENG
IPC: C07C205/00
Filed: 2018-04-04
Abstract: The present invention discloses organic synthesis intermediates 4-nitro-1, 8-naphthalic acid synthesis method, comprises the following steps: 2, 7-dibromo -1, 8-naphthalate methanol, sodium nitrate solution were added to the reaction vessel, the temperature of the solution was raised, controlled the stirring speed, added benzyl propionate solution, continued to react; erbium oxide powder was added to the reaction vessel in batches, continued to react, added oxalic acid solution, adjusted the pH, used bromine phenol solution to extract for multiple times, washed with 4-chlorine phenol solution for several times, recrystallized in the chlorobutane solution, dehydrated with dehydration, got the finished product 4 - nitro I, 8-naphthalene acid.
Patent AU-2001255849-B2 (AU)
Title: PDE-V inhibitors for treatment of parkinson's disease
Inventor: ROYLANCE H H
IPC: A61P43/00
Filed: 2001-04-17
Granted: 2005-12-22
Abstract: The present invention relates generally to novel therapeutic methods for treating Parkinson's Disease by administering cyclic GMP-specific phosphodiesterase inhibitor compounds.
Patent AU-2001271209-B2 (AU)
Title: A composition for an injectable bone mineral substitute material
Inventor: LIDGREN LARS
IPC: A61L27/02
Filed: 2001-07-16
Granted: 2005-12-15
Abstract: The invention refers to an injectable composition for a bone mineral substitute material, which comprises a dry powder mixed with an aqueous liquid. The powder comprises a first reaction component comprising a calcium sulphate hemihydrate with the capability of being hardened to calcium sulphate dihydrate when reacting with said aqueous liquid; a second reaction component, which comprises a calcium phosphate with the capability of being hardened to a calcium phosphate cement when reacting with said aqueous liquid; and at least one accelerator for the reaction of said first and/or second reaction component with said aqueous liquid. A method of producing an injectable bone mineral substitute material is also provided, wherein the composition is mixed in a closed mixing and delivery system for delivery.
Patent AU-2002214014-B2 (AU)
Title: Packaging material for sterile items
Inventor: HOFFMANN MANFRED
IPC: C08J7/048
Filed: 2001-10-12
Granted: 2005-03-17
Abstract: A flexible packaging material (I) for sterile products comprises a film or film laminate (B) having barrier properties comprising a support film (11) of polyamide, polyester or polypropylene having a thin ceramic coating (12) whereby the ceramic coating (12) has a functional coating comprising an inorganic-organic hybrid polymer (13). An Independent claim is included for a process for the production of the packaging material (I) by application of a functional coating of an inorganic-organic hybrid polymer (13) onto the ceramic layer (12) by a pressing process.